scholarly journals Improving Adherence to Weight‐Loss Medication (Liraglutide 3.0 mg) Using Mobile Phone Text Messaging and Healthcare Professional Support

Obesity ◽  
2020 ◽  
Vol 28 (10) ◽  
pp. 1889-1901
Author(s):  
Ang Li ◽  
Michelle Cunich ◽  
Nicholas Fuller ◽  
Katrina Purcell ◽  
Allanah Flynn ◽  
...  
2009 ◽  
Vol 15 (1) ◽  
pp. 17-25 ◽  
Author(s):  
Ben S. Gerber ◽  
Melinda R. Stolley ◽  
Allison L. Thompson ◽  
Lisa K. Sharp ◽  
Marian L. Fitzgibbon

2017 ◽  
Author(s):  
Emily Brindal ◽  
Gilly A Hendrie ◽  
Jill Freyne ◽  
Manny Noakes

BACKGROUND Mobile phone apps may be acceptable to users and could improve retention and adherence over more traditional methods, but there is mixed literature supporting their efficacy. In the weight management space, very little is known about how a mobile phone app integrating features beyond text messaging (short message service) can affect behavior, particularly when combined with face-to-face support. OBJECTIVE The objective of this study was to examine the effectiveness of a mobile phone app when combined with a partial meal replacement program including face-to-face support. This paper compares a static versus supportive app over a 6-month randomized trial for effects on weight loss, weight-related biomarkers, and psychological outcomes. METHODS Overweight and obese adults (71.2% female, 104/146; mean 48.11, SD 11.75 years) were recruited to participate in the weight loss study, and they were randomized on a 1:1 basis using a computer algorithm. The supportive app (n=75) provided information, food intake recording, rewards, prompts for regular interaction through reminders, and the opportunity to review personal compliance with the dietary program. The static app (n=71) included only recipes and weight loss information. Both groups recieved equal amounts of face-to-face support in addition to app. RESULTS The overall reduction in app usage over 24 weeks was lower for the supportive app in comparison with the static app; approximately 39.0% (57/146) of the users were still using the app at week 24. Despite the promising results for app usage, there were no differences in weight loss between groups (F1,128.12=0.83, P=.36). However, it should be noted that almost 60% (49/84) of all participants lost 5% or more of body weight during the trial. No weight-related biomarkers were significantly different between groups. Both groups experienced an increase in positive mood, but this was significantly higher for those who received the static app (F1,118.12=4.93, P=.03). CONCLUSIONS Although the supportive app was well received by users, we found little evidence of the added benefit of this versus the static app in combination with face-to-face support in a community-delivered weight loss program. Future versions of the app may incorporate more unique behavioral techniques beyond those provided by the consultant to improve the potency of the app. CLINICALTRIAL Australian New Zealand Clinical Trials Registry ACTRN12613000547741; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364187 (Archived by WebCite http://www.webcitation.org/6yivwfMI9)


Author(s):  
Dror Dicker ◽  
Assim A. Alfadda ◽  
Walmir Coutinho ◽  
Ada Cuevas ◽  
Jason C.G. Halford ◽  
...  

2017 ◽  
Vol 38 (5) ◽  
pp. 924-931 ◽  
Author(s):  
Page Axley ◽  
Sudha Kodali ◽  
Yong-Fang Kuo ◽  
Sujan Ravi ◽  
Toni Seay ◽  
...  

2008 ◽  
Vol 57 (2) ◽  
pp. 245-248 ◽  
Author(s):  
William Riley ◽  
Jami Obermayer ◽  
Jersino Jean-Mary

2015 ◽  
Vol 22 (Suppl 1) ◽  
pp. A102.3-A103
Author(s):  
M Manzano ◽  
R Jimenez ◽  
A Tristancho ◽  
R Morillo ◽  
C Haro ◽  
...  

2004 ◽  
Vol 115 (1) ◽  
pp. 38-58 ◽  
Author(s):  
Holly R. Wyatt ◽  
James O. Hill

2018 ◽  
Vol 14 (1) ◽  
pp. 93-98 ◽  
Author(s):  
Zubaidah Nor Hanipah ◽  
Elie C. Nasr ◽  
Emre Bucak ◽  
Philip R. Schauer ◽  
Ali Aminian ◽  
...  

BMJ Open ◽  
2021 ◽  
Vol 11 (10) ◽  
pp. e054851
Author(s):  
Birgit Maria Vahlberg ◽  
Erik Lundström ◽  
Staffan Eriksson ◽  
Ulf Holmback ◽  
Tommy Cederholm

ObjectivesTo evaluate effects of mobile phone text-messaging exercise instructions on body composition, cardiometabolic risk markers and self-reported health at 3 months after stroke.DesignRandomised controlled intervention study with per-protocol analyses.SettingUniversity Hospital in Sweden.ParticipantsSeventy-nine patients (mean (SD) age 64 (10) years, 37% female) ≥18 years with good motor function (modified Rankin Scale ≤2) and capable to perform 6 min walking test at hospital discharge were randomised to either intervention (n=40) or control group (n=39). Key exclusion criteria: subarachnoid bleeding, uncontrolled hypertension, severe psychiatric problems or cognitive limitations.InterventionsThe intervention group received beyond standard care, daily mobile phone instructional text messages to perform regular outdoor walking and functional leg exercises. The control group received standard care.Main outcome measuresFat mass and fat-free mass were estimated by bioelectric impedance analysis. Cardiometabolic risk factors like blood lipids, glycated haemoglobin and blood glucose were analysed at baseline and after 3 months.ResultsBoth groups changed favourably in fat-free mass (1.83 kg, 95% CI 0.77 to 2.89; p=0.01, effect size (ES)=0.63 vs 1.22 kg, 95% CI 0.39 to 2.0; p=0.05, ES=0.54) and fat mass (−1.30 kg, 95% CI −2.45 to −0.14; p=0.029, ES=0.41 vs −0.76 kg, 95% CI −1.74 to 0.22; p=0.123, ES=0.28). Also, many cholesterol related biomarkers improved; for example, total cholesterol −0.65 mmol/L, 95% CI −1.10 to −0.2; p=0.06, ES: 0.5 vs −1.1 mmol/L, 95% CI −1.47 to −0.56; p>0.001, ES=0.8. However, there were no between-group differences. At 3 months, 94% and 86%, respectively, reported very good/fairly good health in the text messaging and control groups.ConclusionsNo clear effect of 3 months daily mobile phone delivered training instructions was detected on body composition, cardiovascular biochemical risk factors or self-perceived health. Further research is needed to evaluate secondary prevention efforts in larger populations after recent stroke.Trial registration numberNCT02902367.


Sign in / Sign up

Export Citation Format

Share Document